The founder Prof. Dr. During his professional activity as a research chemist at Bayer AG, Klaus Grohe (* 1934) developed important innovative drugs with great success. In 2001, the couple Klaus and Eva Grohe set up the Klaus Grohe Foundation at the German Chemical Society , which aims to encourage highly qualified young people to turn to the demanding interdisciplinary field of medical chemistry / drug research.
The Klaus Grohe Prize has been awarded since 2020 to scientists who have made excellent work in researching new principles of drug research and whose research results make an important contribution to application. The prize is endowed with 50,000 euros and is awarded every two years.
The Klaus Grohe Foundation honors Dr. Raphaël Rodriguez, Institut Curie, Paris/France in recognition of his pioneering work at the interface of chemistry and biology. The foundation recognizes him in particular for combining preparative organic synthesis with molecular and cell biology and for advancing both chemistry and the understanding of biology at the molecular level in order to discover new therapeutic approaches.
| 2022 | Raphaël Rodriguez, Institut Curie, Paris/France |
| 2020 | Stepan A. Sieber, Technical University of Munich |
Up until 2019, outstanding work by young female scientists (doctoral students and postdocs) at domestic and foreign (European) research institutions was awarded the Klaus Grohe Prize for medicinal chemistry / drug research. On September 20, 2004, the first three "Klaus Grohe Prizes for Medicinal Chemistry" were awarded.
| 2004 | Laurent Bialy, Southampton / Great Britain Thilo J. Heckrodt, Berkeley / USA Daniel Summerer, La Jolla / USA |
| 2005 | Frank Böckler, Erlangen-Nuremberg Dirk Gottschling, Wuppertal Sarah Ulmschneider, Ludwigshafen |
| 2006 | Carl Friedrich Nising, Cambridge / USA Daniel B. Werz, Zurich / Switzerland |
| 2007 | Renata Marcia de Figueiredo, Aachen Tanja Gulder, Würzburg |
| 2008 | Paul Wilhelm Elsinghorst, Bonn Carsten Vock, Saarbrücken |
| 2009 | Andreas Koeberle, Tübingen Stefan Wetzel, Dortmund Georg Wuitschik, Cambridge / UK |
| 2010 | Henning Jacob Jessen, Basel Timo Schmiederer, Berlin Alexander Titz, Zurich |
| 2011 | Ralph Holl, Munster Simon Lucas, Aachen |
| 2012 | Anke Roth, New Haven, CT / USA Marco Schmidt, Cambridge / UK |
| 2013 | Bart ? omiej Krawczyk, Berlin Rainer Wilcken, Cambridge / UK |
| 2014 | Christian Kuttruff, Biberach adRiss |
| 2015 | Jens Schmidt, Hamburg Michael Wilsdorf, Berlin Gunther Zimmermann, Dortmund |
| 2016 | Daniel T. Hog, Berlin Nicole Nischan, Dallas, Texas / USA Dietmar Weichert, Dublin, Ireland |
| 2017 | Tristan Gollnest, Hamburg Cedric Hugelshofer, Berkeley, USA |
| 2018 | Mateja Klika Skopic, Dortmund Matthias Schiedel, Oxford / GB |
| 2019 | Philipp M. Cromm, Berlin, |
Prof. Dr. Daniel Rauh, Technical University of Dortmund (Chair)
Prof. Dr. Karl-Heinz Altmann, ETH Zurich, Switzerland
dr Yves Auberson, Novartis Institutes for BioMedical Research, Basel, Switzerland
Prof. Dr. Dorothea Fiedler, Leibniz Research Institute for Molecular Pharmacology, Berlin
Prof. Dr. Anna Hirsch, Helmholtz Institute for Pharmaceutical Research Saarland
dr Annika Jenmalm Jensen, SciLifeLab, Stockholm, Sweden
Prof. Dr. Stefan Knapp, Johann Wolfgang Goethe University
dr Raphaël Rodriguez, Institute Curie Paris, France
Prof. Dr. Stephan Sieber, Technical University of Munich
Dr. Jasmin Herr
Varrentrappstr. 40 - 42
60486 Frankfurt aM
Tel. +49 69 7917-323
Fax +49 69 7917-1323
Email: j.herr@gdch.de
This page has been machine translated. If you have any feedback or comments please feel free to contact us. 
last modified: 08.03.2023 17:29 H from Translator
